Cardinal Health, Inc. $CAH Shares Acquired by Fortem Financial Group LLC

Fortem Financial Group LLC lifted its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 22.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,631 shares of the company’s stock after purchasing an additional 3,622 shares during the period. Cardinal Health comprises approximately 1.0% of Fortem Financial Group LLC’s portfolio, making the stock its 28th largest position. Fortem Financial Group LLC’s holdings in Cardinal Health were worth $4,148,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of CAH. Norges Bank acquired a new stake in Cardinal Health during the 4th quarter worth $790,344,000. Wellington Management Group LLP lifted its position in Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after acquiring an additional 3,511,579 shares during the last quarter. Holocene Advisors LP boosted its stake in Cardinal Health by 141.4% in the third quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock valued at $302,332,000 after acquiring an additional 1,128,358 shares in the last quarter. Marshall Wace LLP grew its holdings in shares of Cardinal Health by 1,328.1% during the fourth quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock worth $195,484,000 after purchasing an additional 884,648 shares during the last quarter. Finally, Barclays PLC grew its holdings in shares of Cardinal Health by 109.3% during the third quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock worth $248,658,000 after purchasing an additional 827,446 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

Shares of NYSE:CAH opened at $222.08 on Friday. The company has a 50-day simple moving average of $204.34 and a 200-day simple moving average of $209.27. Cardinal Health, Inc. has a one year low of $137.75 and a one year high of $233.60. The stock has a market capitalization of $52.01 billion, a price-to-earnings ratio of 33.96, a PEG ratio of 1.21 and a beta of 0.52.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business’s revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the company posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, research analysts forecast that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is 31.19%.

Analysts Set New Price Targets

Several research firms have recently weighed in on CAH. Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Monday, June 15th. Citigroup dropped their price target on Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Wells Fargo & Company cut their price target on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. TD Cowen boosted their price objective on Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a research note on Friday, May 1st. Finally, William Blair assumed coverage on Cardinal Health in a report on Tuesday, April 28th. They issued an “outperform” rating for the company. Fourteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $246.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.